10803 related articles for article (PubMed ID: 10547546)
1. Combining suramin and a chimeric toxin directed to basic fibroblast growth factor receptors increases therapeutic efficacy against human melanoma in an animal model.
Davol PA; Garza S; Frackelton AR
Cancer; 1999 Nov; 86(9):1733-41. PubMed ID: 10547546
[TBL] [Abstract][Full Text] [Related]
2. Wortmannin, a phosphoinositide 3-kinase inhibitor, selectively enhances cytotoxicity of receptor-directed-toxin chimeras in vitro and in vivo.
Davol PA; Bizuneh A; Frackelton AR
Anticancer Res; 1999; 19(3A):1705-13. PubMed ID: 10470104
[TBL] [Abstract][Full Text] [Related]
3. Targeting human prostatic carcinoma through basic fibroblast growth factor receptors in an animal model: characterizing and circumventing mechanisms of tumor resistance.
Davol PA; Frackelton AR
Prostate; 1999 Aug; 40(3):178-91. PubMed ID: 10398280
[TBL] [Abstract][Full Text] [Related]
4. Autocrine down-regulation of basic fibroblast growth factor receptors causes mitotoxin resistance in a human melanoma cell line.
Davol P; Beitz JG; Frackelton AR
J Invest Dermatol; 1995 Jun; 104(6):916-21. PubMed ID: 7769258
[TBL] [Abstract][Full Text] [Related]
5. Saporin toxins directed to basic fibroblast growth factor receptors effectively target human ovarian teratocarcinoma in an animal model.
Davol P; Beitz JG; Mohler M; Ying W; Cook J; Lappi DA; Frackelton AR
Cancer; 1995 Jul; 76(1):79-85. PubMed ID: 8630880
[TBL] [Abstract][Full Text] [Related]
6. Anti-B16-F10 melanoma activity of a basic fibroblast growth factor-saporin mitotoxin.
Ying W; Martineau D; Beitz J; Lappi DA; Baird A
Cancer; 1994 Aug; 74(3):848-53. PubMed ID: 8039113
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxic effects of basic FGF and heparin binding EGF conjugated with cytotoxin saporin on vascular cell cultures.
Chen C; Li J; Micko CJ; Pierce GF; Cunningham MR; Lumsden AB
J Surg Res; 1998 Feb; 75(1):35-41. PubMed ID: 9614854
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast growth factor complexed to the cytotoxin saporin is growth inhibitory but not cytotoxic for embryonal carcinoma cells.
Miller K; Wilder PJ; Rizzino A
Cytotechnology; 1993; 13(2):69-78. PubMed ID: 7764580
[TBL] [Abstract][Full Text] [Related]
9. Fibroblast growth factor-2-toxin induced cytotoxicity: differential sensitivity of co-cultured vascular smooth muscle cells and endothelial cells.
Lin PH; Ren D; Hirko MK; Kang SS; Pierce GF; Greisler HP
Atherosclerosis; 1998 Apr; 137(2):277-89. PubMed ID: 9622271
[TBL] [Abstract][Full Text] [Related]
10. The mitotoxin, basic fibroblast growth factor-saporin, effectively targets human prostatic carcinoma in an animal model.
Davol P; Frackelton AR
J Urol; 1996 Sep; 156(3):1174-9. PubMed ID: 8709341
[TBL] [Abstract][Full Text] [Related]
11. Antitumor activity of basic fibroblast growth factor-saporin mitotoxin in vitro and in vivo.
Beitz JG; Davol P; Clark JW; Kato J; Medina M; Frackelton AR; Lappi DA; Baird A; Calabresi P
Cancer Res; 1992 Jan; 52(1):227-30. PubMed ID: 1309225
[TBL] [Abstract][Full Text] [Related]
12. Expression and activities of a recombinant basic fibroblast growth factor-saporin fusion protein.
Lappi DA; Ying W; Barthelemy I; Martineau D; Prieto I; Benatti L; Soria M; Baird A
J Biol Chem; 1994 Apr; 269(17):12552-8. PubMed ID: 8175664
[TBL] [Abstract][Full Text] [Related]
13. Biphasic effect of the mitotoxin bFGF-saporin on bovine lens epithelial cell growth: effect of cell density and extracellular matrix.
David T; Tassin J; Lappi DA; Baird A; Courtois Y
J Cell Physiol; 1992 Dec; 153(3):483-90. PubMed ID: 1447311
[TBL] [Abstract][Full Text] [Related]
14. The biologic effects of growth factor-toxin conjugates in models of vascular injury depend on dose, mode of delivery, and animal species.
Yu C; Cunningham M; Rogers C; Dinbergs ID; Edelman ER
J Pharm Sci; 1998 Nov; 87(11):1300-4. PubMed ID: 9811480
[TBL] [Abstract][Full Text] [Related]
15. The basic fibroblast growth factor-saporin mitotoxin acts through the basic fibroblast growth factor receptor.
Lappi DA; Maher PA; Martineau D; Baird A
J Cell Physiol; 1991 Apr; 147(1):17-26. PubMed ID: 1645359
[TBL] [Abstract][Full Text] [Related]
16. Therapy of human T-cell acute lymphoblastic leukaemia in severe combined immunodeficient mice with two different anti-CD7-saporin immunotoxins containing hindered or non-hindered disulphide cross-linkers.
Flavell DJ; Boehm DA; Okayama K; Kohler JA; Flavell SU
Int J Cancer; 1994 Aug; 58(3):407-14. PubMed ID: 7519586
[TBL] [Abstract][Full Text] [Related]
17. Nontoxic doses of suramin enhance activity of doxorubicin in prostate tumors.
Zhang Y; Song S; Yang F; Au JL; Wientjes MG
J Pharmacol Exp Ther; 2001 Nov; 299(2):426-33. PubMed ID: 11602651
[TBL] [Abstract][Full Text] [Related]
18. Autocrine transformation by chimeric signal peptide-basic fibroblast growth factor: reversal by suramin.
Yayon A; Klagsbrun M
Proc Natl Acad Sci U S A; 1990 Jul; 87(14):5346-50. PubMed ID: 2164679
[TBL] [Abstract][Full Text] [Related]
19. Recombinant mitotoxin basic fibroblast growth factor-saporin reduces venous anastomotic intimal hyperplasia in the arteriovenous graft.
Chen C; Mattar SG; Hughes JD; Pierce GF; Cook JE; Ku DN; Hanson SR; Lumsden AB
Circulation; 1996 Oct; 94(8):1989-95. PubMed ID: 8873678
[TBL] [Abstract][Full Text] [Related]
20. Effect of basic fibroblast growth factor-saporin (bFGF-SAP) conjugate on bovine choriocapillary endothelial cells.
Kim YH; Kim HS; Yoo JS
Korean J Ophthalmol; 2004 Dec; 18(2):121-31. PubMed ID: 15635825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
